February 9, 2021 | Compliance An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report Are you aware of recent changes from EMA pertaining to manufacturers of chemically synthesized drugs and biological products? Barbara Unger Principal Consultant 10 Minute Read
January 10, 2020 | Press Releases Validant Adds New Partners and Client Engagement to European Team Carla Nieser 2 Minute Read
January 4, 2020 | Quality The Eight Ways Nitrosamines Can Get in Your Product Barbara Unger Principal Consultant 9 Minute Read